Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Buying What Markets Ignore
Buying What Markets Ignore
BusinessLine

Motilal Oswal Mutual Fund has entered the contra fund category with an NFO in May, adding to a relatively under-populated segment that currently houses only three schemes: SBI Contra, Invesco India Contra and Kotak India EQ Contra Fund. The launch…

thehindu.com - The Hindu Bureau - KIA crosses 400 million passenger milestone in April
KIA crosses 400 million passenger milestone in April
The Hindu

Kempegowda International Airport (KIA), Bengaluru, crosses the 400 million passenger milestone since its Airport Opening Day (AOD), in April, 2026. The airport also registered a strong growth in the financial year 2025-26, driven by international…

thehindubusinessline.com - SRF: On The Road to Recovery
SRF: On The Road to Recovery
BusinessLine

SRF reported its Q4FY26 results in early May and provided a strong outlook. We had earlier recommended a hold on the stock in August 2025 because valuations were elevated at 44 times one-year forward earnings even when factoring for expectations of…

medpagetoday.com - Claire Panosian Dunavan - Opinion | How Low Can America Go?
Opinion | How Low Can America Go?
Medpage Today

For many doctors like me, Donald G. McNeil Jr.'s byline will always inspire respect. A New York Times (NYT) reporter since the 1970s, he first earned his medical stripes in the 1990s as a foreign correspondent covering HIV/AIDS in South Africa.

marketbeat.com - Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Bessemer Group Inc.
Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Bessemer Group Inc.
MarketBeat

Bessemer Group Inc. lifted its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 861,152.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…

cnbc.com - Natasha Abellard - Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
CNBC

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it can live up to the hype. Icotyde went to market after the Food and Drug Administration approved it in mid-March for…

thehindubusinessline.com - MFs Cut Their Cash Cushion
MFs Cut Their Cash Cushion
BusinessLine

Active equity mutual funds have sharply cut their cash buffers over the past year. Cash holdings fell from ₹3 lakh crore in April 2025 to ₹1.68 lakh crore in April 2026, while cash as a share of active equity fund AUM declined from…

marketbeat.com - Lawood & Co. Takes Position in AbbVie Inc. $ABBV
Lawood & Co. Takes Position in AbbVie Inc. $ABBV
MarketBeat

Lawood & Co. bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,555 shares of the company's…

marketbeat.com - AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co.
AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co.
MarketBeat

Lockheed Martin Investment Management Co. grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 12.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned…

marketbeat.com - AustralianSuper Pty Ltd Trims Stock Holdings in The Goldman Sachs Group, Inc. $GS
AustralianSuper Pty Ltd Trims Stock Holdings in The Goldman Sachs Group, Inc. $GS
MarketBeat

AustralianSuper Pty Ltd trimmed its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 83.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor…

marketbeat.com - The Goldman Sachs Group, Inc. $GS Shares Acquired by Stephens Inc. AR
The Goldman Sachs Group, Inc. $GS Shares Acquired by Stephens Inc. AR
MarketBeat

Stephens Inc. AR increased its position in shares of The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 11.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…

thehindubusinessline.com - Mutual Funds returns
Mutual Funds returns
BusinessLine

EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNPP Balanced Advantage Fund HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt EQUITY - LARGE CAP FUNDS Canara Robeco Large Cap Fund…

marketbeat.com - Vanguard Group Inc. Acquires 290,307 Shares of Zenas BioPharma, Inc. $ZBIO
Vanguard Group Inc. Acquires 290,307 Shares of Zenas BioPharma, Inc. $ZBIO
MarketBeat

Vanguard Group Inc. lifted its holdings in Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) by 25.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,453,065 shares of the…

marketbeat.com - DNB Asset Management AS Has $43.65 Million Holdings in Pfizer Inc. $PFE
DNB Asset Management AS Has $43.65 Million Holdings in Pfizer Inc. $PFE
MarketBeat

DNB Asset Management AS raised its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 38.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,753,086 shares of the biopharmaceutical…

marketbeat.com - Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of 'Moderate Buy' by Analysts
Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of 'Moderate Buy' by Analysts
MarketBeat

Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been given an average rating of 'Moderate Buy' by the twelve brokerages that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold…

Receive a Daily briefing on Pharma Industry News

Get Started